CHD sped cognitive decline; choosing an antidiabetic for elderly patients

Friday, June 21, 2019

This week's top stories in cardiology:

  1. Cognitive decline sped up after CHD
  2. Genetic analysis links PCSK9 inhibition and CV mortality
  3. Which antidiabetic for elderly patients? It depends on their CV risk
  4. Pivotal trial shows HFrEF benefits from baroreceptor stimulation

You can contact the Cardiocast by emailing us at podcasts@mdedge.com or you can interact with us on Twitter @MDedgeCardio

How to Listen

Podcast Participants

Jim Dwyer, MD
Jim Dwyer MD, FACC, FSCAI, is a cardiologist and avid horseman in Prescott, Ariz. Trained at Saint Louis University, he spent more than 30 years in interventional cardiology. He recently hung up his lead apron and has joined a private cardiology practice. Dr. Dwyer has been producing health segments for radio broadcast for 20 years. He has no disclosures.



More Episodes from Cardiocast (ARCHIVE)

View All Episodes